Colgate and Dabur are two of the leading FMCG companies in India, competing in various product categories such as toothpaste, oral care, and personal care. Here, we’ll compare these two giants in the Indian market, analyzing their market share, financial performance, stock price performance, valuation metrics, and shareholding patterns.
Market Share
Category | Colgate | Dabur |
---|---|---|
Toothpaste Market (by value) as on March 2020 | 48.3% | 13.4% |
Natural/Herbal Toothpaste | – | ~75% (combined with Patanjali) |
Financial Performance
Metric | Colgate | Dabur | |
---|---|---|---|
Market Cap | As of May 14, 2024 | ₹ 76,645.55 crore | ₹ 98,224.13 crore |
Total Income | As of December 31, 2023 | ₹ 1,413.54 crore | ₹ 2,516.22 crore |
Net Profit | As of December 31, 2023 | ₹ 330.11 crore | ₹ 428.12 crore |
Earning Per Share | As of December 31, 2023 | ₹ 2.42 | ₹ 12.14 |
Stock Price Performance
Metric | Colgate | Dabur |
---|---|---|
1-Year Return | 73.25% | 6.98% |
Valuation Metrics (as on 14 May, 2024)
Metric | Colgate | Dabur |
---|---|---|
Price-to-Earnings (P/E) Ratio | 60.97 | 52.86 |
Price-to-Book Value (P/BV) Ratio | 44.12 | 9.87 |
Dividend Yield | 1.50% | 0.99% |
Shareholding Pattern (March 2024)
Company | Promoter Holding |
---|---|
Colgate | 51.0% |
Dabur | 66.25% |
Brokerage Calls
Dabur: Of the 40 analysts tracking Dabur India, 43% have a Buy rating on the stock, 28% have an Outperform rating, 25% have and hold rating, while the rest 6% have an Underperform and Sell rating, respectively.
Colgate: Of the 31 analysts tracking Colgate Palmolive, 10% have a Buy and Outperform rating on the stock, 35% have an Hold rating on the stock, 19% have an underperform rating and the rest 26% have a Sell rating.
In conclusion, while Colgate leads the toothpaste market, Dabur has a strong presence in the natural/herbal segment and a higher market capitalization. Colgate has outperformed the market in terms of stock price performance, but both companies have healthy financials and promoter holdings.
Disclaimer: The information provided in this article is for educational and informational purposes only. It should not be considered as professional financial advice. Investing in stocks involves risks, and readers should conduct their own research and due diligence before making any investment decisions.
Note: The stock prices and financial data mentioned in this article are as of May 14, 2024, the time of writing. Data sourced from NSEindia.com and Angleone.in